Nora Cavani is a molecular biologist and the Founder & CEO of Alba Health, a healthtech company translating cutting-edge microbiome science into prevention-focused care for families. Her work focuses on understanding how early-life gut microbiome development shapes immune health, metabolism, and long-term disease risk.

Prior to founding Alba Health, Nora worked as a Manager at Boston Consulting Group. Her entrepreneurial journey began after successfully reversing her own severe eczema through diet-based gut health interventions, which inspired her to explore the role of the microbiome in chronic disease prevention.

Nora co-founded Alba Health together with Prof. Willem de Vos, one of the world’s leading microbiome scientists known for discovering Akkermansia muciniphila. Today, Alba Health collaborates with a scientific team representing more than 1,600 scientific publications and is running the PREVENT Study, the largest company-led longitudinal study on children’s gut health.

Through her work, Nora aims to advance a new prevention paradigm in healthcare — one that begins early in life by supporting healthy microbiome development to help reduce the risk of allergies, autoimmune conditions, and other chronic diseases later in life.

At the Longevity Med Summit 2026, Nora will explore how childhood microbiome development shapes immune resilience and long-term health outcomes, highlighting why the foundations of longevity may begin much earlier than previously thought.

How Childhood Microbiome Development Shapes Lifelong Health and Disease Risk

Longevity science often focuses on interventions later in life — diet, supplements, exercise, and metabolic optimization. However, growing evidence suggests that many biological systems shaping lifelong health are established much earlier.

In this talk, molecular biologist Nora Cavani explores how the gut microbiome develops during childhood and why this early period plays a critical role in immune development and long-term disease risk. Emerging research shows that disruptions to early microbial colonization — influenced by factors such as antibiotics, delivery mode, and diet — may contribute to the rising prevalence of allergies and other chronic inflammatory diseases.

Drawing on recent discoveries in microbiome science, this session will explore how supporting healthy microbiome development in childhood may help reduce disease risk and shape healthier long-term outcomes.